John Petkau
Affiliations: | University of British Columbia, Vancouver, Vancouver, BC, Canada |
Area:
StatisticsGoogle:
"John Petkau"Parents
Sign in to add mentor| Herman Chernoff | grad student | 1975 | Stanford | |
| (Sequential Medical Trials for Comparing an Experimental with a Standard Treatment) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Karim ME, Tremlett H, Zhu F, et al. (2020) Dealing with Treatment-confounder Feedback and Sparse Follow-up in Longitudinal studies - Application of a Marginal Structural Model in a Multiple Sclerosis Cohort. American Journal of Epidemiology |
| Högg T, Zhao Y, Gustafson P, et al. (2019) Adjusting for differential misclassification in matched case-control studies utilizing health administrative data. Statistics in Medicine |
| Kingwell E, Leray E, Zhu F, et al. (2019) Multiple sclerosis: effect of beta interferon treatment on survival. Brain : a Journal of Neurology |
| Zhang T, Kingwell E, Zhu F, et al. (2017) Effect of adherence to the first-generation injectable immunomodulatory drugs on disability accumulation in multiple sclerosis: a longitudinal cohort study. Bmj Open. 7: e018612 |
| Högg T, Petkau J, Zhao Y, et al. (2017) Bayesian analysis of pair-matched case-control studies subject to outcome misclassification. Statistics in Medicine |
| Kondo Y, Zhao Y, Petkau J. (2017) Identification of treatment responders based on multiple longitudinal outcomes with applications to multiple sclerosis patients. Statistics in Medicine |
| Karim ME, Petkau J, Gustafson P, et al. (2016) Comparison of statistical approaches dealing with time-dependent confounding in drug effectiveness studies. Statistical Methods in Medical Research |
| Karim ME, Gustafson P, Petkau J, et al. (2016) Comparison of Statistical Approaches for Dealing With Immortal Time Bias in Drug Effectiveness Studies. American Journal of Epidemiology |
| Zhang T, Kingwell E, De Jong HJ, et al. (2016) Association between the use of selective serotonin reuptake inhibitors and multiple sclerosis disability progression. Pharmacoepidemiology and Drug Safety |
| Hartung HP, Kappos L, Goodin DS, et al. (2015) Predictors of disease activity in 857 patients with MS treated with interferon beta-1b. Journal of Neurology |